sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
tctttacaggcaaagtcagtaat | 1220 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tctttacaggcaaagtcagtaat | 1220 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tctttacaggcaaagtcagtaat | 1220 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tctttacaggcaaagtcagtaat | 1220 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttcagtactgtataaagtga | 1040 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttcagtactgtataaagtga | 1040 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttcagtactgtataaagtga | 1040 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttcagtactgtataaagtga | 1040 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttcagtactgtataaagtga | 2387 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tttcagtactgtataaagtga | 2387 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tttcagtactgtataaagtga | 1578 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tttcagtactgtataaagtga | 1578 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tttcagtactgtataaagtga | 1578 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttcagtactgtataaagtga | 1578 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttcagtactgtataaagtga | 2387 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttcagtactgtataaagtga | 2387 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atcttctattgtctgggactcag | 536 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atcttctattgtctgggactcag | 536 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atcttctattgtctgggactcag | 266 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atcttctattgtctgggactcag | 266 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atcttctattgtctgggactcag | 266 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atcttctattgtctgggactcag | 266 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atcttctattgtctgggactcag | 536 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
atcttctattgtctgggactcag | 536 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
caacagcacagttactggact | 5722 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
caacagcacagttactggact | 5722 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
caacagcacagttactggact | 6791 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
caacagcacagttactggact | 6791 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
caacagcacagttactggact | 6791 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
caacagcacagttactggact | 6791 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
caacagcacagttactggact | 5722 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
caacagcacagttactggact | 5722 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agctagccaagcagcaaatct | 5613 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agctagccaagcagcaaatct | 5613 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agctagccaagcagcaaatct | 6668 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agctagccaagcagcaaatct | 6668 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agctagccaagcagcaaatct | 6668 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
agctagccaagcagcaaatct | 6668 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
agctagccaagcagcaaatct | 5613 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agctagccaagcagcaaatct | 5613 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ggcctgtgtgctttgtagagcca | 3013 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ggcctgtgtgctttgtagagcca | 3013 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ggcctgtgtgctttgtagagcca | 3013 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ggcctgtgtgctttgtagagcca | 3013 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagcaatcctgaagttcctgagc | 4111 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagcaatcctgaagttcctgagc | 4111 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagcaatcctgaagttcctgagc | 3573 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagcaatcctgaagttcctgagc | 3573 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagcaatcctgaagttcctgagc | 4111 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tagcaatcctgaagttcctgagc | 4111 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tagcaatcctgaagttcctgagc | 3573 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagcaatcctgaagttcctgagc | 3573 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaacacatcagccaacctggaat | 611 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
aaacacatcagccaacctggaat | 611 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
aaacacatcagccaacctggaat | 341 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaacacatcagccaacctggaat | 341 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaacacatcagccaacctggaat | 611 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaacacatcagccaacctggaat | 611 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaacacatcagccaacctggaat | 341 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaccaattgccttattaa | 983 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaccaattgccttattaa | 983 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaccaattgccttattaa | 1521 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaccaattgccttattaa | 1521 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaccaattgccttattaa | 1521 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gagtaccaattgccttattaa | 1521 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gagtaccaattgccttattaa | 2330 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaccaattgccttattaa | 2330 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaccaattgccttattaa | 2330 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gagtaccaattgccttattaa | 2330 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gagtaccaattgccttattaa | 983 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaccaattgccttattaa | 983 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagagctgcttctaaataacaaa | 1989 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagagctgcttctaaataacaaa | 1989 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagagctgcttctaaataacaaa | 1989 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagagctgcttctaaataacaaa | 1989 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaatgggcactttcttgtctt | 7000 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
aaatgggcactttcttgtctt | 7000 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
aaatgggcactttcttgtctt | 5911 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaatgggcactttcttgtctt | 5911 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaatgggcactttcttgtctt | 7000 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaatgggcactttcttgtctt | 7000 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaatgggcactttcttgtctt | 5911 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaatgggcactttcttgtctt | 5911 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttctatgagaaaaaatgtcaac | 1205 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttctatgagaaaaaatgtcaac | 1205 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttctatgagaaaaaatgtcaac | 1205 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttctatgagaaaaaatgtcaac | 1205 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttctatgagaaaaaatgtcaac | 1743 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tttctatgagaaaaaatgtcaac | 1743 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tttctatgagaaaaaatgtcaac | 1743 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttctatgagaaaaaatgtcaac | 1743 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aattgacagataaaatacgaagt | 2077 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aattgacagataaaatacgaagt | 2077 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aattgacagataaaatacgaagt | 2077 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aattgacagataaaatacgaagt | 2077 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gccaggacagagttgagaccaca | 5391 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gccaggacagagttgagaccaca | 5391 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gccaggacagagttgagaccaca | 5391 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gccaggacagagttgagaccaca | 5391 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atggaggatgagttattctggga | 59 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["2->2"],"infos":["OTHER"]}] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.